First Manhattan’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-94	Closed	-$139	–	1035
2024 Q1	$139	Hold	94	–	–	﹤0.01%	1384
2023 Q4	$102	Hold	94	–	–	﹤0.01%	1413
2023 Q3	$110	Hold	94	–	–	﹤0.01%	1457
2023 Q2	$132	Hold	94	–	–	﹤0.01%	1398
2023 Q1	$141	Hold	94	–	–	﹤0.01%	1489
2022 Q4	$109	Hold	94	–	–	﹤0.01%	1646
2022 Q3	$0	Hold	94	–	–	﹤0.01%	1599
2022 Q2	$0	Hold	94	–	–	﹤0.01%	1621
2022 Q1	$0	Hold	94	–	–	﹤0.01%	1648
2021 Q4	$0	Hold	94	–	–	﹤0.01%	1629
2021 Q3	$0	Sell	94 -2,000	-96%	-$5.13K	﹤0.01%	1638
2021 Q2	$5K	Buy	2,094 +2,000	+2,128%	+$5.17K	﹤0.01%	1383
2021 Q1	$0	Hold	94	–	–	﹤0.01%	1522
2020 Q4	$0	Hold	94	–	–	﹤0.01%	1376
2020 Q3	$0	Hold	94	–	–	﹤0.01%	1398
2020 Q2	$0	Hold	94	–	–	﹤0.01%	1434
2020 Q1	$0	Hold	94	–	–	﹤0.01%	1413
2019 Q4	$0	Hold	94	–	–	﹤0.01%	1338
2019 Q3	$0	Hold	94	–	–	﹤0.01%	1369
2019 Q2	$0	Hold	94	–	–	﹤0.01%	1414
2019 Q1	$0	Buy	+94	New	+$117	﹤0.01%	1431

Other funds holding LCTX